LIVE

Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video

Trending Now

Trade Thaw: US Lifts Curbs On Ethane & Chip Design Software Exports To China

Queens Driving School Busted For Running Bribe-for-License Scam For Illegal Immigrants

June Payrolls Preview: Anything Below 60K We Get A Stagflationary Recession "Growth Scare"

Delhi Bans Fuel for Older Vehicles in Pollution Crackdown

India's Hindustan Zinc Eyes Five Year Timeline To Move Into Rare Earth Metals

Japan Finally Admits Its Carmakers Have Been Paying All Trump Tariff Costs As Trade Talks Collapse

The Best Trade Of 2025 Is Starting To Wobble: Here's How To Hedge It

JPMorgan Trading Desk: The Momentum "Unwind" Is The Primary Topic For Clients

Trump Announces Trade Deal With Vietnam; Includes 20% Tariffs, 40% Tax On Transshipping

Tariff Derangement Syndrome(s)

Merck ends development of Covid drug it acquired from OncoImmune

Business April 15, 2021

This article is being updated.

Previous article: PepsiCo revenue rises 6.8% despite unbalanced economic recovery outside of the U.S. Prev Next article: PepsiCo tops estimates as pandemic snacking helps fuel 6.8% revenue gain Next

via CNBC April 15th 2021

MixedTimes.com
Business
Merck ends development of Covid drug it acquired from OncoImmune

© 2015-2025 MixedTimes All Rights Reserved.

Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video